PQQ Side Effects: What the Safety Data Actually Shows

The short answer

PQQ has a clean safety record at the dose people actually take. Twenty milligrams a day of PQQ disodium salt has cleared two FDA GRAS notifications with no-questions letters and a European Food Safety Authority novel-food assessment, and the human trials that exist reported no significant adverse effects. Reported side effects are mild and uncommon: headache, stomach upset, and sleep changes in either direction.

Two honest caveats sit underneath that. First, “no significant adverse effects” comes from studies enrolling 10 to 41 people for three days to twelve weeks, which is not a large safety database. Nobody has studied what taking PQQ for five years does. Second, there is a specific kidney signal in animal toxicology that gets either ignored entirely or misrepresented as alarming, and it deserves to be understood accurately rather than skipped.

⚠ CLAIM (wellness): PQQ disodium salt at up to 20 mg per day has been assessed as safe for healthy adults by EFSA and has FDA GRAS notifications with no-questions letters. This reflects the absence of demonstrated harm at studied doses over weeks to months, not evidence of long-term safety or of any health benefit. Basis: EFSA 2017; FDA GRAS Notices 701 and 709; Nakano 2014. Lane: wellness-guidance.

What is actually reported

Effect	How often	What to know
Headache	Uncommon	The most frequently mentioned complaint. Usually early and self-limiting.
Stomach upset, nausea, heartburn	Uncommon	Typically on an empty stomach. Taking PQQ with food usually resolves it.
Sleep changes	Uncommon, and unpredictable	PQQ is marketed for sleep, and one open-label study reported improved sleep onset and duration. A subset of users report the opposite: lighter sleep, vivid dreams, or difficulty settling. Direction seems to vary by person.
Drowsiness or fatigue	Uncommon	Reported by some users, usually in the first week or two.
Dizziness	Rare	Mentioned in consumer reporting, not a trial finding.
Serious adverse events	None reported in human trials	Across all published trials at 20 mg/day, no significant adverse effects or tolerance issues were attributed to PQQ disodium salt.

Anecdotal, from community reports and not shown in controlled trials: the two most common patterns people describe are a mild headache in the first few days, and a change in sleep quality that can go either way. Some report noticeably more vivid dreams. Neither has been characterized in a trial, and self-reported effects from a supplement with a strong “energy” marketing frame are exactly where expectation shapes what people notice. Treat these as things to watch for, not things to expect.

The kidney question, properly explained

Search PQQ safety and you will find either “PQQ is nephrotoxic” or nothing at all. Both are wrong. Here is the actual literature.

The 1989 rat study. Watanabe and colleagues injected rats intraperitoneally with 11.5 mg/kg of PQQ per day for four days and produced necrotic and degenerative changes in the proximal tubular epithelium along with blood in the urine. This is the study everyone cites, and route matters enormously. Injecting a compound bypasses absorption and first-pass metabolism entirely. It says very little about swallowing a capsule.

The 2014 oral toxicology. The dedicated acute and subchronic oral toxicity work on PQQ disodium salt in rats found increased relative kidney weight with associated histopathology, focal basophilic changes and tubular atrophy, at high doses and in female rats only. A follow-up 28-day study in females found increased urinary protein and crystals. Crucially, these changes were reversible and resolved during the recovery period, and they occurred at doses far above human intake. That work established the no-observed-adverse-effect level used to justify the human safety margin.

Where humans land. The FDA’s assessment supports intakes up to roughly 0.3 mg per kilogram of body weight per day, which is about 21 mg for a 70 kg adult, and EFSA assessed 20 mg per day as safe under intended conditions of use. In other words, the standard 20 mg capsule sits right at the level regulators evaluated, with the animal findings occurring far above it.

The reasonable conclusion is not that PQQ damages kidneys. It is that the kidney is the organ where a signal appeared first when doses were pushed hard, which is a sensible reason for anyone with existing kidney impairment to check with a clinician before adding it, and a sensible reason not to take double or triple doses because a label said “extra strength.”

⚠ Contradiction: Watanabe et al. (1989) reported nephrotoxicity in rats after intraperitoneal PQQ at 11.5 mg/kg/day, while Nakano et al. (2014) oral toxicology found only reversible, high-dose, female-specific kidney changes and established a NOAEL supporting current human intakes. Both are kept here with provenance. The reconciling factor is route and dose: injected administration bypasses absorption and is not a model for oral supplementation. Lane: educational.

Who should be careful

• Reduced kidney function. The clearest group. Given where the animal signal landed, this is a genuine reason to ask your clinician rather than a generic disclaimer.
• Pregnancy and breastfeeding. No data. PQQ occurs naturally in breast milk, which people sometimes read as reassurance about supplementing; it is not. Microgram amounts in milk say nothing about a 20 mg daily capsule.
• Children. No data, no studied dose, no reason.
• Anyone taking prescription medication. Not because a specific interaction is known, but because none has been looked for. PQQ has no well-characterized drug interactions, and that reflects an absence of study rather than a demonstrated absence of risk. It is a redox-active compound, so the theoretical concern most worth raising with an oncologist is concurrent use during chemotherapy or radiotherapy, the same conversation that applies to other strong antioxidants.
• People taking more than 20 mg. Products offering 40 or 60 mg are above the level regulators assessed. There is no evidence more works better, and the entire safety margin you are relying on was calculated around the lower number.

What we do not know

The longest human PQQ trial ran twelve weeks. That is the honest boundary of the safety data. Long-term daily supplementation at 50 to 200 times dietary intake has not been studied in humans, and the compound has only been widely available for about fifteen years, so there is no long observational record either.

That is not a reason for alarm. It is a reason for proportion. PQQ looks well tolerated over months, and anyone claiming to know it is safe over decades is guessing. If you take it continuously, periodic kidney function checks with your clinician are a cheap and sensible precaution, particularly past middle age.

Quality problems are a safety issue too

A meaningful share of what people experience from a supplement comes from what else is in the capsule. PQQ is expensive per gram, sold in milligram quantities, and impossible to assess by sight or taste, which makes it a candidate for underdosing and for contamination with heavy metals from poorly controlled raw material. An independent, lot-matched certificate of analysis covering identity, potency, and heavy metals is not a luxury for this ingredient. We go through what to look for in choosing a PQQ supplement.

The bottom line

At 20 mg a day of PQQ disodium salt, side effects are mild, uncommon, and mostly limited to headache, stomach upset, and unpredictable sleep changes. The regulatory record is genuinely good. The animal kidney findings are real but occurred at doses far above human intake, were reversible, and in the most alarming study came from injection rather than swallowing. The two sensible precautions are to talk to a clinician if your kidney function is reduced, and not to exceed the studied dose because a bottle promised more.

For what PQQ is actually supposed to do and how thin the efficacy evidence is, see our PQQ pillar, and for how it compares to the better-evidenced option in the same aisle, PQQ vs CoQ10.

Educational information only, not medical advice, and not evaluated by the FDA. PQQ is not a treatment for any disease, and nothing here is a dosing protocol. Talk to a clinician before supplementing, particularly if you have reduced kidney function, are pregnant or breastfeeding, are undergoing cancer treatment, or take prescription medication.